Evidence map›Paper›PMID 16585762›Full record

ArticleJournal of bacteriology2006

Comparative genomics of NAD biosynthesis in cyanobacteria.

Svetlana Y Gerdes, Oleg V Kurnasov, Konstantin Shatalin, Boris Polanuyer, Roman Sloutsky, Veronika Vonstein, Ross Overbeek, Andrei L Osterman

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of bacteriology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Regulation of NADPathogens (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Characterization of the Nicotinamide Adenine Dinucleotide Biosynthesis Pathway and Regulatory Mechanisms in Streptococcus mutans.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  6. Review
  7. Article
  8. Nitrilase GiNIT fromInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. NADThe Journal of biological chemistry · 2020
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Svetlana Y GerdesBurnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Oleg V Kurnasov
Konstantin Shatalin
Boris Polanuyer
Roman Sloutsky
Veronika Vonstein
Ross Overbeek
Andrei L Osterman
Sanford Burnham Prebys Medical Discovery Institute · USNew York University · USSpringhouse · USThe Ohio State University · US

Funding

Targeting cofactor biosynthesis in biodefense pathogensR01AI059146 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI OSTERMAN, ANDREI L · 2005 to 2009
$1.9M
NIAID NIH HHS 1R01 AI 059146-01A2NIAID NIH HHS R01 AI059146
6 · The paper itself

Abstract

Biosynthesis of NAD(P) cofactors is of special importance for cyanobacteria due to their role in photosynthesis and respiration. Despite significant progress in understanding NAD(P) biosynthetic machinery in some model organisms, relatively little is known about its implementation in cyanobacteria. We addressed this problem by a combination of comparative genome analysis with verification experiments in the model system of Synechocystis sp. strain PCC 6803. A detailed reconstruction of the NAD(P) metabolic subsystem using the SEED genomic platform (http://theseed.uchicago.edu/FIG/index.cgi) helped us accurately annotate respective genes in the entire set of 13 cyanobacterial species with completely sequenced genomes available at the time. Comparative analysis of operational variants implemented in this divergent group allowed us to elucidate both conserved (de novo and universal pathways) and variable (recycling and salvage pathways) aspects of this subsystem. Focused genetic and biochemical experiments confirmed several conjectures about the key aspects of this subsystem. (i) The product of the slr1691 gene, a homolog of Escherichia coli gene nadE containing an additional nitrilase-like N-terminal domain, is a NAD synthetase capable of utilizing glutamine as an amide donor in vitro. (ii) The product of the sll1916 gene, a homolog of E. coli gene nadD, is a nicotinic acid mononucleotide-preferring adenylyltransferase. This gene is essential for survival and cannot be compensated for by an alternative nicotinamide mononucleotide (NMN)-preferring adenylyltransferase (slr0787 gene). (iii) The product of the slr0788 gene is a nicotinamide-preferring phosphoribosyltransferase involved in the first step of the two-step non-deamidating utilization of nicotinamide (NMN shunt). (iv) The physiological role of this pathway encoded by a conserved gene cluster, slr0787-slr0788, is likely in the recycling of endogenously generated nicotinamide, as supported by the inability of this organism to utilize exogenously provided niacin. Positional clustering and the co-occurrence profile of the respective genes across a diverse collection of cellular organisms provide evidence of horizontal transfer events in the evolutionary history of this pathway.

Indexed as

Genome, BacterialAmide SynthasesCyanobacteriaEscherichia coliGene Transfer, HorizontalGlutamineModels, BiologicalMultigene FamilyNADNiacinNiacinamideNicotinamide MononucleotideNicotinamide PhosphoribosyltransferaseNucleotidyltransferasesPentosyltransferasesSyntenyAmide SynthasesGlutamineglutamine-synthetase adenylyltransferaseNADNAD+ synthaseNiacinNiacinamideNicotinamide MononucleotideNicotinamide Phosphoribosyltransferasenicotinate mononucleotideNucleotidyltransferasesPentosyltransferases

Identifiers

PMID16585762
PMCPMC1446974
OpenAlexW1967515719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.